HIV - Technical work
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.

Events

Publications

All →
WHO optimal antiretroviral dosing guidance: recommendations for dosing medicines for HIV prevention and treatment in paediatric populations

This guidance presents updated recommendations on antiretroviral drug dosing for neonates, infants and children, drawing on recent pharmacokinetic evidence,...

WHO consolidated operational handbook on sexually transmitted infections

WHO's Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections (STIs) has consolidated all existing normative guidance on STIs...

Needle and syringe programmes for people who inject drugs: operational guide

This operational guide provides practical, evidence-based guidance to support countries in planning, implementing and scaling up needle and syringe programmes...

WHO updated recommendations on HIV clinical management: recommendations for a public health approach

This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral...

WHO guidelines on the management of advanced HIV disease

Advanced HIV disease is the major cause of AIDS-related deaths among people living with HIV. In 2017, WHO recommended a package of care that should ...

WHO consultation on the use of broadly neutralizing antibodies for postnatal prophylaxis against the vertical transmission of HIV: meeting report, 22–23 May and 25 November 2024

Building on growing momentum from multiple stakeholders, this report summarizes the proceedings from a consultation held to convene a multidisciplinary...

Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030

The Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C, and Sexually Transmitted Infections (2026–2030) outlines a unified...

Opioid agonist maintenance treatment as an essential health service: implementation guidance on mitigating disruption of services for treatment of opioid dependence

Opioid agonist maintenance treatment (OAMT) for people with opioid dependence is proven to be safe and effective in addressing a broad range of health...